Futibatinib
| Futibatinib | |
|---|---|
| Term | Futibatinib |
| Short definition | fusion protein (FYOO-zhun PROH-teen) A fusion gene protein formed by joining parts of two different genes together. Fusion genes can occur naturally in the body by transferring DNA between chromosomes. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Futibatinib - (FYOO-tih-BA-tih-feather) A drug used to treat adults with intrahepatic cholangiocarcinoma (a type of cancer that forms in the bile ducts inside the liver) that has spread or has not spread through surgery can be removed and has an FGFR2 gene fusion or other alteration in the structure of the FGFR2 gene. It is used in patients whose cancer has already been treated. It is also being studied in the treatment of other types of cancer. Futibatinib blocks a protein called FGFR, which can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called Lytgobi
External links
- Medical encyclopedia article on Futibatinib
- Wikipedia's article - Futibatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski